Literature DB >> 30773635

The crucial role of ZEB2: From development to epithelial-to-mesenchymal transition and cancer complexity.

Masoumeh Fardi1,2, Mohammadreza Alivand3, Behzad Baradaran1,2, Majid Farshdousti Hagh2, Saeed Solali2,4,5.   

Abstract

Zinc finger E-box binding homeobox 2 (ZEB2) is a DNA-binding transcription factor, which is mainly involved in epithelial-to-mesenchymal transition (EMT). EMT is a conserved process during which mature and adherent epithelial-like state is converted into a mobile mesenchymal state. Emerging data indicate that ZEB2 plays a pivotal role in EMT-induced processes such as development, differentiation, and malignant mechanisms, for example, drug resistance, cancer stem cell-like traits, apoptosis, survival, cell cycle arrest, tumor recurrence, and metastasis. In this regard, the understanding of mentioned subjects in the development of normal and cancerous cells could be helpful in cancer complexity of diagnosis and therapy. In this study, we review recent findings about the biological properties of ZEB2 in healthy and cancerous states to find new approaches for cancer treatment.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  EMT; ZEB2; cancer; cancer stem cell; epigenetics; target therapy

Year:  2019        PMID: 30773635     DOI: 10.1002/jcp.28277

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  26 in total

Review 1.  Mesenchymal stem cell-derived exosomes: a promising vector in treatment for diabetes and its microvascular complications.

Authors:  Xinjie Cui; Liangxi Zhu; Ruixia Zhai; Bin Zhang; Fanyong Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Circ_0001247 functions as a miR-1270 sponge to accelerate cervical cancer progression by up-regulating ZEB2 expression level.

Authors:  Wenshuang Wang; Anli Xu; Manyin Zhao; Jianan Sun; Lingyun Gao
Journal:  Biotechnol Lett       Date:  2021-01-01       Impact factor: 2.461

3.  Comprehensive bioinformatics analysis of functional molecules in colorectal cancer.

Authors:  Tao Meng; Zhangzhang Lan; Xiaoling Zhao; Li Niu; Chuan Chen; Wenyong Zhang
Journal:  J Gastrointest Oncol       Date:  2022-02

Review 4.  Diabetes complications and extracellular vesicle therapy.

Authors:  Setareh Soltani; Kamran Mansouri; Shahram Parvaneh; Avnesh S Thakor; Flemming Pociot; Reza Yarani
Journal:  Rev Endocr Metab Disord       Date:  2021-10-14       Impact factor: 6.514

Review 5.  The Mechanism of Long Non-coding RNA in Cancer Radioresistance/Radiosensitivity: A Systematic Review.

Authors:  Wenhan Wu; Shijian Zhang; Jia He
Journal:  Front Pharmacol       Date:  2022-05-05       Impact factor: 5.988

Review 6.  microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Ulrich Brinkmann; Simon Auslaender
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

Review 7.  MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2021 Sep-Oct       Impact factor: 4.069

8.  Metastasis Inhibition by Cell Type Specific Expression of BRMS1 Gene under The Regulation of miR200 Family Response Elements.

Authors:  Samila Farokhimanesh; Mahdi Forouzandeh Moghadam; Marzieh Ebrahimi; Zahra Sadat Hashemi
Journal:  Cell J       Date:  2021-05-26       Impact factor: 2.479

9.  ZEB2, interacting with MDM2, contributes to the dysfuntion of brain microvascular endothelial cells and brain injury after intracerebral hemorrhage.

Authors:  Qingbao Guo; Manli Xie; Miao Guo; Feiping Yan; Lihong Li; Rui Liu
Journal:  Cell Cycle       Date:  2021-08-02       Impact factor: 5.173

Review 10.  Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark.

Authors:  Shanshan Zhao; Xue Zhang; Shuo Chen; Song Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.